YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance

被引：0
|
作者：
C. N. Rathcke
J. S. Johansen
H. Vestergaard
机构：
[1] University of Copenhagen,Department of Endocrinology, Herlev Hospital
[2] University of Copenhagen,Department of Rheumatology, Herlev Hospital
来源：
Inflammation Research | 2006年 / 55卷
关键词：
Inflammation; Type 2 diabetes; YKL-40; CRP; Iinsulin resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective and design. YKL-40 participates in inflammatory states and vascular processes, which implies that comparison can be made with other inflammatory markers associated with insulin resistance and type 2 diabetes (T2D). In the present study levels of plasma YKL-40 and serum hsCRP were evaluated in patients with T2D.
引用
收藏
页码：53 / 59
页数：6
相关论文
共 50 条
  • [1] YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance
    Rathcke, CN
    Johansen, JS
    Vestergaard, H
    INFLAMMATION RESEARCH, 2006, 55 (02) : 53 - 59
  • [2] YKL-40 concentrations are not elevated in gestational diabetes
    Schaller, Georg
    Brix, Johanna Maria
    Placher-Sorko, Gudrun
    Hoellerl, Florian
    Schernthaner, Gerit-Holger
    Schernthaner, Guntram
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 (04) : 339 - 343
  • [3] High YKL-40 levels predict mortality in patients with type 2 diabetes
    Persson, Frederik
    Rathcke, Camilla Noelle
    Gall, Mari-Anne
    Parving, Hans-Henrik
    Vestergaard, Henrik
    Rossing, Peter
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 96 (01) : 84 - 89
  • [4] YKL-40 is elevated in patients with peripheral arterial disease and diabetes or pre-diabetes
    Batinic, Klaudija
    Hoebaus, Clemens
    Grujicic, Milan
    Steffan, Angelika
    Jelic, Finka
    Lorant, David
    Hoertenhuber, Thomas
    Hoellerl, Florian
    Brix, Johanna-Maria
    Schernthaner, Guntram
    Koppensteiner, Renate
    Schernthaner, Gerit-Holger
    ATHEROSCLEROSIS, 2012, 222 (02) : 557 - 563
  • [5] YKL-40 levels are independently associated with albuminuria in type 2 diabetes
    Rondbjerg, Anne K.
    Omerovic, Emina
    Vestergaard, Henrik
    CARDIOVASCULAR DIABETOLOGY, 2011, 10
  • [6] YKL-40: A biomarker for early nephropathy in type 2 diabetic patients and its association with inflammatory cytokines
    Umapathy, Dhamodharan
    Dornadula, Sireesh
    Krishnamoorthy, Ezhilarasi
    Mariappanadar, Vairamani
    Viswanathan, Vijay
    Mohanram, Ramkumar Kunka
    IMMUNOBIOLOGY, 2018, 223 (11) : 718 - 727
  • [7] Elevated YKL-40 and low sAPPβ: YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLD
    Alcolea, Daniel
    Irwin, David J.
    Illan-Gala, Ignacio
    Munoz, Laia
    Clarimon, Jordi
    McMillan, Corey T.
    Fortea, Juan
    Blesa, Rafael
    Lee, Edward B.
    Trojanowski, John Q.
    Grossman, Murray
    Lleo, Alberto
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (02) : 180 - 186
  • [8] Elevated serum YKL-40 levels in patients with Kawasaki disease
    Kim, K. Y.
    Ahn, Y.
    Kim, D. Y.
    Kim, Ho-Seong
    Kim, D. S.
    BIOMARKERS, 2017, 22 (3-4) : 326 - 330
  • [9] YKL-40 in type 2 diabetic patients with different levels of albuminuria
    Brix, Johanna-M.
    Hoellerl, Florian
    Koppensteiner, Renate
    Schernthaner, Guntram
    Schernthaner, Gerit-H.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 (06) : 589 - 596
  • [10] Plasma YKL-40 levels are elevated in patients with chronic heart failure
    Rathcke, Camilla Noelle
    Kistorp, Caroline
    Raymond, Ilan
    Hildebrandt, Per
    Gustafsson, Finn
    Lip, Gregory Y. H.
    Faber, Jens
    Vestergaard, Henrik
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2010, 44 (02) : 92 - 99
12345